• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Proactive Dermatologic Care Reduces Symptom Severity and Boosts Quality of Life in NSCLC

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Enhanced dermatologic management reduces skin rash and improves quality of life for patients with EGFR-mutant non-small cell lung cancer. Read More

ASCO 2025: Racial Disparities and Advanced Staging in Early-Onset Colorectal Cancer

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles A study of early-onset colorectal cancer found significant racial disparities, with younger patients more frequently diagnosed at advanced stages. Read More

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles The FDA grants fast track designation to TEV-53408, a promising treatment for celiac disease designed to address gluten intolerance and improve patient outcomes. Read More

HHS Cancels Millions in Pandemic Influenza mRNA Vaccine Development Grants

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles The announcement is set to affect multiple grants awarded to Moderna, which is developing mRNA-1018, a candidate vaccine against avian influenza. Read More

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Zongertinib shows significant benefits in managing symptoms and improving quality of life for patients with HER2-mutated non-small cell lung cancer. Read More

Elecsys PRO-C3 Test Aims to Improve Precision Evaluation of Liver Fibrosis Severity

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles The test offers health care professionals a simple and efficient method of identifying patients with liver fibrosis of varying severity. Read More
« Older Entries
Next Entries »

Recent Content

  • WHO grants nonproprietary name to ovarian cancer cell therapy
  • Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
  • Carvykti label updated to include survival benefit data in myeloma
  • Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Inflammatory markers from routine blood tests predict survival in multiple myeloma: a Systematic Review and meta-analysis
  • FDA approves ziftomenib to treat some relapsed leukemia patients
  • (no title)
  • The challenge of non-transplant eligible, newly diagnosed multiple myeloma
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT